Publications by authors named "Dave Whitston"

Claim this Profile
I
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.
Kenneth Thress, Terry Macintyre, Haiyun Wang, Dave Whitston, Zhong-Ying Liu

Mol Cancer Therยท July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis